Your browser doesn't support javascript.
loading
Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review.
Kruger, Davida F; Isaacs, Diana; Hughes, Lucille; Miller, Eden; Bailey, Timothy S.
Afiliação
  • Kruger DF; Division of Endocrinology, Diabetes, Bone & Mineral, Henry Ford Health System, Detroit, MI, USA.
  • Isaacs D; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hughes L; Diabetes Education and Program Design, Catholic Health, Melville, NY, USA.
  • Miller E; Endocrinology and Metabolism Institute, Diabetes and Obesity Care LLC, Bend, OR, USA.
  • Bailey TS; Endocrinology and Metabolism Institute, AMCR Institute, Escondido, CA, USA.
Postgrad Med ; 136(3): 246-254, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38497381
ABSTRACT
Use of innovative technologies such as continuous glucose monitoring (CGM) and insulin delivery systems have been shown to be safe and effective in helping patients with diabetes achieve significantly improved glycemic outcomes compared to their previous therapies. However, these technologies are underutilized in many primary care practices. This narrative review discusses some of the clinical and economic benefits of tubeless insulin delivery devices and discusses how this technology can overcome the main obstacles inherent to use of conventional insulin delivery devices.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Infusão de Insulina / Automonitorização da Glicemia / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Insulina Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas de Infusão de Insulina / Automonitorização da Glicemia / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Insulina Idioma: En Ano de publicação: 2024 Tipo de documento: Article